GlassScriptPhysician profile
Matthew T Maynard
NPI 1861617417
$1,486.75
in general payments reported to CMS, 2019-2025
26 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $144 · 2020: $13.24 · 2021: $106 · 2022: $188 · 2023: $155 · 2024: $519 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $833 · Travel and Lodging: $203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.83 |
| Travel and Lodging | $203.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $252.49 | 2023-2024 | Da Vinci Surgical System |
| Sage Therapeutics, LLC | $175.77 | 2024-2025 | Zurzuvae |
| Astellas Pharma US INC | $147.88 | 2024-2025 | Veozah |
| Daiichi Sankyo INC. | $116.11 | 2022-2023 | Injectafer |
| Hologic Sales and Service, LLC | $101.22 | 2021-2025 | Novasure, Aptima |
| Heron Therapeutics, INC. | $98.91 | 2024-2025 | Zynrelef |
| Myriad Women'S Health, INC. | $62.77 | 2023 | |
| Avanos Medical | $56.94 | 2021-2025 | On-Q Pump and Accessories |
| Supernus Pharmaceuticals, INC. | $54.69 | 2025 | Qelbree |
| Roche Diagnostics Corporation | $50.12 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $37.25 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $36.38 | 2022-2023 | |
| Baxter Healthcare | $35.22 | 2024 | Perclot |
| Smith+Nephew, INC. | $31.77 | 2025 | Stravix Pl |
| Therapeuticsmd, INC. | $31.62 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $28.98 | 2019-2021 | |
| Medtronic, INC. | $26.71 | 2022 | |
| Amag Pharmaceuticals, INC. | $23.12 | 2019 | |
| Ethicon US, LLC | $21.52 | 2025 | Axert |
| Allergan, INC. | $19.16 | 2022 | |
| Lsi Solutions INC | $16.41 | 2023 | Fornisee |
| Aspira Women'S Health INC | $14.26 | 2019 | |
| Bard Access Systems, INC. | $13.66 | 2019 | |
| Saluda Medical Americas, INC. | $12.70 | 2024 | Evoke |
| Teleflex LLC | $11.56 | 2019 | |
| Organon LLC | $9.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Maynard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.